E5
Extracellular Matrix (ECM)
Dr George Galea, EMBL; Dr Muzamil Majid Khan , EMBL
EMBLEM Technology Transfer GmbH
Challenge
The extracellular matrix (ECM) is a complex and dynamic network of structural proteins, glycosaminoglycans, proteoglycans, and bioactive factors that surrounds every cell in the body. It makes up a substantial proportion of human tissue and plays a central role not only in providing mechanical support but also in regulating cell behaviour during tissue development, repair, and regeneration. Despite its fundamental importance in biology and medicine, there is currently no truly off-the-shelf human ECM scaffold available. Existing alternatives, including xenogeneic products and decellularized tissues, suffer from variability and limited biological relevance, while synthetic hydrogels lack essential human biological cues.
Technology
Reproducible, human-derived ECM that addresses the limitations of current products, offering the following key commercial advantages: • Scalable & cost-effective: efficient, high-consistency production suitable for commercial-scale applications. • Ethical & regulatory-friendly: donor- and animal-free workflow simplifies Good Manufacturing Practice (GMP) compliance and eliminates xenogeneic risk. • Fully human and structurally complex: replicates native ECM architecture and proteomic richness, offering translation and clinically relevant materials with reduced immunogenicity. • Customisable: organ- and patient-specific ECM compositions achievable through tailored cell sources and growth conditions
Commercial Opportunity
We offer licensing and collaboration opportunities as well as a technology evaluation program.
Development Status
Material Optimization
Patent Situation
Technology protected by patent application
Further Reading
doi:10.1126/scitranslmed.adj3087
